CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Prem
June 23 2008 - 4:01PM
PR Newswire (US)
-Study shows angina at one year associated with significantly
higher incidence of depression- PALO ALTO, Calif., June 23
/PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (NASDAQ:CVTX) today
announced that the Archives of Internal Medicine published results
of a major study demonstrating that one in five patients studied
experienced chest pain one year after a myocardial infarction (MI),
or heart attack, and that this angina was associated with
significantly elevated rates of depression among cardiac patients
in the registry. PREMIER (Prospective Registry Evaluating
Myocardial Infarction: Events and Recovery) was a "real-world"
observational study in nearly 2,500 patients specifically designed
to characterize patients' health status one year after a heart
attack. Researchers found a significant (p
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Sep 2024 to Oct 2024
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Oct 2023 to Oct 2024